FEMY Margin dodolan resik Femasys Inc.

Logo perusahaan publik Femasys Corp (FEMY)

The low cyclicality of demand for gynecological services ensures the resilience of Femasys Inc. (FEMY) to crises, which is confirmed by the projected sales margins, where the metric level stands at -640.90. Physician confidence is based on an innovative approach to minimally invasive diagnostics. Meanwhile, the company adheres to basic environmental standards by minimizing plastic in packaging and optimizing office energy consumption.

Rentabilitas dodolan resik femasys.com (FEMY): kanggo periode 04.07.2022 - 19.11.2026

Ringkesan rincian data analitis Femasys Corp (FEMY)

- nilai pasar lan prakiraan target analis:
Analisis umum perusahaan:Femasys Corporation - FEMY
Produk asil prodhuksi Femasys Inc

The uniqueness of Femasys Inc. non-surgical methods allows the company to independently determine service pricing while optimizing clinic expenses. This metric measures the share of net profit in every dollar of revenue, capturing the final business efficiency after all costs. Analyzing this metric helps distinguish temporary write-offs from a systemic decline in profitability. Investors require this to assess the asset's financial stability. The trend of the company's net margin ratio clearly demonstrates the actual conversion of sales into capital.

Analisis perusahaan pesaing

Intuitive Surgical, Inc. (ISRG) - Margin resik|Margin resik Danaher Corporation (DHR)|Margin resik Becton Dickinson & Co|Rentabilitas dodolan resik STE (STERIS plc)|Rentabilitas dodolan miturut bathi resik WST (West Pharmaceutical Services Inc)|Rentabilitas resik perusahaan BAX|Masimo Corporation - Rentabilitas dodolan miturut bathi resik|Rentabilitas resik perusahaan STVN (Stevanato Group SpA)|TFX: Rentabilitas dodolan miturut bathi resik|Margin dodolan perusahaan Merit Medical Corp MMSI|NVST: Margin dodolan resik|ICUI - Margin dodolan perusahaan|XRAY (Sirona Dental Systems) - Margin dodolan resik|Margin resik LeMaitre Vascular Inc LMAT|Margin resik AtriCure Corp (ATRC)|Margin dodolan resik STAAR Surgical Corp (STAA)|Margin resik niagenbioscience.com NAGE|ZimVie Inc. - Margin resik|ANGO - Margin resik|Margin dodolan perusahaan Cerus Corp CERS|TKNO (Alpha Teknova Inc) - Rentabilitas dodolan miturut bathi resik|Monogram Technologies Inc - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik STSS|InfuSystem Holdings, Inc. (INFU) - Margin dodolan perusahaan|Margin dodolan resik UTMD|KORU Medical - Rentabilitas dodolan resik|Nyxoah S.A - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik MBOT|PDEX - Margin resik|ZTEK (Zentek) - Rentabilitas dodolan resik|ELUT (Elutia Inc) - Rentabilitas dodolan miturut bathi resik|MLSS - Margin dodolan perusahaan|Margin resik NEXGEL, Inc.|RVP (Retractable Technologies) - Rentabilitas resik perusahaan|Margin dodolan resik HBIO|Margin dodolan resik Meihua Medical Technologies (MHUA)|Margin dodolan resik POAI (Predictive Oncology)|CJMB - Rentabilitas dodolan miturut bathi resik|ATRI: Rentabilitas dodolan miturut bathi resik|NeuroMetrix, Inc. (NURO) - Rentabilitas dodolan miturut bathi resik